Chalfont St Giles, UK – GE Healthcare, a unit of GE (NYSE: GE) announced today that it has acquired SeqWright, Inc., a provider of nucleic acid sequencing and other genomic services. The acquisition adds complementary genomics capabilities to Clarient, a unit of GE Healthcare and a leader in the fast-growing molecular diagnostics sector. The deal […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN), a leading developer, manufacturer and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today announced that its Board of Directors has, after careful review and consideration together with its financial and legal advisors, unanimously rejected Roche’s revised offer to acquire Illumina […]
CARLSBAD, Calif.,– Life Technologies Corporation (NASDAQ: LIFE) today announced that it is working with several partners to develop applications for its Ion Personal Genome Machine (PGM™) system in HLA (human leukocyte antigen) analysis. HLAs are found on the surfaces of all cells in the body, and individuals vary widely in the combination of HLA sub-types […]
Roche released the following statement in response to the announcement by Illumina, Inc. (NASDAQ: ILMN) that its Board of Directors has recommended that shareholders not tender their shares to Roche’s increased offer. “We are disappointed that Illumina’s Board of Directors has rejected Roche’s increased $51.00 cash offer and continues to rebuff our attempts to engage […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN), a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today sent a third letter to its stockholders highlighting Illumina’s tremendous growth prospects in the next generation sequencing market. The letter urges stockholders to reject Roche’s efforts to […]
CAMBRIDGE, MA – Knome Inc., the human genome interpretation company, announced today that it has been selected by Illumina, Inc., (NASDAQ: ILMN) as a partner in the Illumina Genome Network (IGN). As part of the agreement, IGN customers will have access to preferential pricing for Knome’s genome interpretation tools and services. The agreement also calls […]
Letter urges Illumina shareholders to tender shares into Roche’s increased offer and vote the GOLD proxy card Roche (SIX: RO, ROG; OTCQX: RHHBY) today sent a second letter to shareholders of Illumina, Inc. (NASDAQ: ILMN) urging them to tender their shares into Roche’s increased offer and vote for Roche’s independent director nominees and other proposals […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced estimated first quarter revenue of approximately $270 million. This number is based on a preliminary estimate and remains subject to review by Illumina’s independent registered public accounting firm. Analysis of the remainder of the income statement is incomplete, but the company expects non-GAAP EPS to be at […]
LEXINGTON, Mass. AND CHICAGO, Ill.,– RainDance Technologies, Inc., the Digital Biology™ company, today announced the worldwide availability of its new panel for cancer mutation screening research using any next-generation sequencing (NGS) system. The RainDance Cancer Hotspot Panel enables researchers to simultaneously interrogate more than 13,000 cancer “hotspots” across 54 genes. Developed with researchers from the […]
Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012
CARLSBAD, Calif.,– Life Technologies Corporation (NASDAQ: LIFE) will exhibit products across the spectrum of basic, translational and clinical cancer research during the American Association of Cancer Research (AACR) Annual Meeting 2012, taking place March 31 – April 4, in Chicago, Illinois. In addition, several of Life’s customers and collaborators will present research findings. “From basic […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
